Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab
Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab have?
Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab has 87 citations in the OpenAlex counts ScholarIQ stores.
When was Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab published?
Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab has 2018 year in the ScholarIQ index.
What is the open-access status of Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab?
Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab has bronze oa status in the ScholarIQ index.
What is the DOI of Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab?
The DOI for Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab is on the source record.
What is the PMID of Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab?
The PMID for Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab is on the source record.
What is the OpenAlex record for Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab?
The OpenAlex for Immunological remission in PLA2R-antibody–associated membranous nephropathy: cyclophosphamide versus rituximab is on the source record.